Even medical pros are skipping health insurance over cost, per WaPo

The Washington Post is out with a story that says the affordability crisis in U.S. health insurance has reached the people who actually deliver care. According to the report, even doctors and pharmacists are now dropping coverage as premiums climb.

The Durham case study

WaPo profiles Joshua and Ashley Durham, a physician and pharmacist who run a family medicine practice in Boise, Idaho. For the first time in their lives, they have no health insurance for their family.

The couple originally bought ACA marketplace coverage when they opened their practice at the end of 2023, but say rising premiums pushed them to opt out entirely this year.

Why it matters for markets

The story lands as Washington is actively debating the fate of enhanced ACA premium tax credits. If subsidies lapse, marketplace enrollment could shrink, hitting insurers with exposure to the individual market and pushing more consumers into the uninsured pool.

That flows straight through to managed care margins, hospital bad-debt expense, and PBM volumes.


Do you want to see how to make more plays? Do you want to find gains yourself?

Unusual Whales helps you find market opportunities through our market tide, historical options flow, GEX, and much, much more.

Create a free account here to start conquering the market with Unusual Whales.


The broader affordability backdrop

Health care workers historically carry insurance at higher rates than the general workforce, so the fact that clinicians themselves are opting out is a signal about how far premiums have moved.

Recent surveys have shown a rising share of Americans skipping care outright due to cost, a trend that tends to accelerate whenever premium hikes outpace wage growth.

Options market and stocks to watch

Watch for reactions in names most exposed to the individual and Medicare Advantage markets, plus the pharmacy and hospital chains that feel the downstream effect of an uninsured population.

  • UnitedHealth (UNH): watch for headline sensitivity to any ACA subsidy resolution given its scale across MA and commercial books.
  • Elevance Health (ELV): watch for exposure to the individual exchange business if enrollment softens.
  • Centene (CNC): watch as one of the largest ACA marketplace insurers, most directly tied to subsidy policy.
  • CVS Health (CVS): watch for read-through on Aetna commercial and pharmacy volumes if uninsured rates rise.
  • HCA Healthcare (HCA): watch for bad-debt and uncompensated care commentary if coverage losses accelerate.

Want more market intelligence? Create your free Unusual Whales account for options flow, market tide, GEX, and the full toolkit.

Track UNH on Unusual Whales
Unusual Whales does not confirm the information's truthfulness or accuracy of the associated references, data, and cannot verify any of the information. Any content on this site or related pages are not intended to provide legal, tax, investment or insurance advice. Unusual Whales Inc. is not registered as a securities broker-dealer or an investment adviser with the U.S. Securities and Exchange Commission, the Financial Industry Regulatory Authority (“FINRA”) or any state securities regulatory authority. Nothing on Unusual Whales should be construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security by Unusual Whales or any third party. Options, investing, trading is risky, and losses are more expected than profits. Please do own research before investing. Please only subscribe after reading our full terms and understanding options and the market, and the inherent risks of trading. It is highly recommended not to trade on this, or any, information from Unusual Whales. Markets are risky, and you will likely lose some or all of your capital. Please check our terms for full details.
Any content on this site or related pages are not intended to provide legal, tax, investment or insurance advice. Unusual Whales Inc. is not registered as a securities broker-dealer or an investment adviser with the U.S. Securities and Exchange Commission, the Financial Industry Regulatory Authority (“FINRA”) or any state securities regulatory authority. Nothing on Unusual Whales should be construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security by Unusual Whales or any third party. Certain investment planning tools available on Unusual Whales may provide general investment education based on your input. You are solely responsible for determining whether any investment, investment strategy, security or related transaction is appropriate for you based on your personal investment objectives, financial circumstances and risk tolerance. You should consult your legal or tax professional regarding your specific situation. See terms for more information.